Chairman and Executive Director Cai Dongchen increased his stake in CSPC PHARMA (01093) by 3 million shares at a price of HK$8.81 per share.
On October 17th, Chairman and Executive Director Cai Dongchen increased his holdings in Chiho Pharmaceutical Group (01093) by 3 million shares, each priced at 8.81 Hong Kong dollars, for a total amount of 26.43 million Hong Kong dollars.
The latest information from the Hong Kong Stock Exchange shows that on October 17th, Chairman and Executive Director Dong Chen Tsai increased his holdings of CSPC PHARMA (01093) by 3 million shares, with a price of 8.81 Hong Kong dollars per share, for a total amount of 26.43 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 2.842 billion shares, with the latest shareholding ratio of 24.67%.
Related Articles
Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.
Boeing Company (BA.US) has received approval from the FAA to increase the monthly production limit of 737 MAX aircraft to 42.
MRAM, sponsored by Taiwan Semiconductor Manufacturing Co., Ltd. ADR(TSM.US), makes a significant breakthrough.
Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.
Boeing Company (BA.US) has received approval from the FAA to increase the monthly production limit of 737 MAX aircraft to 42.
MRAM, sponsored by Taiwan Semiconductor Manufacturing Co., Ltd. ADR(TSM.US), makes a significant breakthrough.
RECOMMEND
